Anaphylaxis Clinical Trial
Official title:
Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit: a French Retrospective Multicenter Study
Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, accompanied with an increased number of hospitalizations. Although rare, this condition is often associated with a significant morbidity and mortality. The mortality rate has been recently estimated at 0.84 (95% CI, 0.79 to 0.88) per million per year in the French adult population. Age, chronic medication and cardiac or pulmonary comorbidities have been reported to increase the risk of a severe reaction. Obesity, age and cardiovascular comorbidities have been identified as risk factors for fatal anaphylaxis. However, the risk factors for death after ICU admission have not been elucidated yet.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04475003 -
Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis
|
||
Recruiting |
NCT04615065 -
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
|
||
Recruiting |
NCT06065137 -
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
|
N/A | |
Completed |
NCT00047918 -
Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
|
N/A | |
Active, not recruiting |
NCT03953482 -
Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis
|
||
Recruiting |
NCT05112367 -
Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier
|
||
Completed |
NCT03366298 -
Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers
|
Phase 4 | |
Completed |
NCT02958605 -
Smartphone Apps for Pediatric Resuscitation
|
N/A | |
Completed |
NCT04696822 -
Bioavailability of Nasal Epinephrine
|
Phase 1 | |
Completed |
NCT03942692 -
What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
|
||
Completed |
NCT02854969 -
Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device
|
N/A | |
Completed |
NCT03282929 -
Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)
|
Phase 1 | |
Recruiting |
NCT01326741 -
Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis
|
N/A | |
Recruiting |
NCT06445374 -
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges
|
Phase 1 | |
Completed |
NCT01217138 -
Make up for the Epinephrine Autoinjector
|
Phase 4 | |
Completed |
NCT02424136 -
PEAnut Anaphylaxis Predictors
|
N/A | |
Completed |
NCT01432522 -
A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine
|
N/A | |
Completed |
NCT02028065 -
A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101)
|
Phase 1 | |
Active, not recruiting |
NCT01247415 -
Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine
|
N/A | |
Completed |
NCT00868842 -
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
|
N/A |